Targeted Therapeutics Market Size, Share, Growth, and Forecast 2032

Targeted Therapeutics Market

Targeted Therapeutics Market - By Type (Monoclonal Antibodies, Small Molecular Inhibitors, Prodrug, and Nano-Particulate Antibody Conjugates), By Application (Breast Cancer, Leukemia, Colorectal Cancer, Lymphoma, Renal Cancer, Multiple Sclerosis, Wet Age-Related Macular Degeneration, and Lung Cancer), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032-

Category: Pharmaceutical Report Format : PDF Pages: 100 Report Code: ZMR-6577 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 108.54 Billion USD 202.93 Billion 7.2% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Targeted Therapeutics Market, 2018–2028(USD Billion)
    • 2.2. Targeted Therapeutics Market: Snapshot
  • Chapter 3. Global Targeted Therapeutics Market– Application Analysis
    • 3.1. Targeted Therapeutics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Focus on cancer medicine development and cytotoxic & non-specific chemotherapies have shifted to mulecularly targeted and rationally developed drugs having potential of providing more efficiency with lesser side-effects. This, in turn, will promulgate growth of targeted therapeutics market in upcoming years.
      • 3.2.2. Need for developing specific cancer medicines for treating patients and necessity of comprehensively knowing concepts & ideas related to genetics & biulogy of individual will expedite targeted therapeutics market revenue.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Type
      • 3.4.2. Market attractiveness analysis By Application
      • 3.4.3. Market attractiveness analysis By Distribution Channel
  • Chapter 4. Global Targeted Therapeutics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Targeted Therapeutics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Targeted Therapeutics Market– Type Analysis
    • 5.1. Global Targeted Therapeutics Market overview: By Type
      • 5.1.1. Global Targeted Therapeutics Market share, By Type, 2020 and 2028
    • 5.2. Monoclonal Antibodies
      • 5.2.1. Global Targeted Therapeutics Market by Monoclonal Antibodies, 2018–2028(USD Billion)
    • 5.3. Small Mulecular Inhibitors
      • 5.3.1. Global Targeted Therapeutics Market by Small Mulecular Inhibitors, 2018–2028(USD Billion)
    • 5.4. Prodrug
      • 5.4.1. Global Targeted Therapeutics Market by Prodrug, 2018–2028(USD Billion)
    • 5.5. Nano-Particulate Antibody Conjugates
      • 5.5.1. Global Targeted Therapeutics Market by Nano-Particulate Antibody Conjugates, 2018–2028(USD Billion)
  • Chapter 6. Global Targeted Therapeutics Market– Application Analysis
    • 6.1. Global Targeted Therapeutics Market overview: By Application
      • 6.1.1. Global Targeted Therapeutics Market share, By Application, 2020 and 2028
    • 6.2. Breast Cancer
      • 6.2.1. Global Targeted Therapeutics Market by Breast Cancer , 2018–2028(USD Billion)
    • 6.3. Leukemia
      • 6.3.1. Global Targeted Therapeutics Market by Leukemia, 2018–2028(USD Billion)
    • 6.4. Lung Cancer
      • 6.4.1. Global Targeted Therapeutics Market by Lung Cancer, 2018–2028(USD Billion)
    • 6.5. Culorectal Cancer
      • 6.5.1. Global Targeted Therapeutics Market by Culorectal Cancer, 2018–2028(USD Billion)
    • 6.6. Lymphoma
      • 6.6.1. Global Targeted Therapeutics Market by Lymphoma, 2018–2028(USD Billion)
    • 6.7. Renal Cancer
      • 6.7.1. Global Targeted Therapeutics Market by Renal Cancer, 2018–2028(USD Billion)
    • 6.8. Multiple Sclerosis
      • 6.8.1. Global Targeted Therapeutics Market by Multiple Sclerosis, 2018–2028(USD Billion)
    • 6.9. Wet Age-Related Macular Degeneration
      • 6.9.1. Global Targeted Therapeutics Market by Wet Age-Related Macular Degeneration, 2018–2028(USD Billion)
  • Chapter 7. Global Targeted Therapeutics Market– Distribution Channel Analysis
    • 7.1. Global Targeted Therapeutics Market overview: By Distribution Channel
      • 7.1.1. Global Targeted Therapeutics Market share, By Distribution Channel, 2020 and 2028
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global Targeted Therapeutics Market by Hospital Pharmacies, 2018–2028(USD Billion)
    • 7.3. Online Pharmacies
      • 7.3.1. Global Targeted Therapeutics Market by Online Pharmacies, 2018–2028(USD Billion)
    • 7.4. Retail Pharmacies
      • 7.4.1. Global Targeted Therapeutics Market by Retail Pharmacies, 2018–2028(USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Amgen, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Sanofi
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. AstraZeneca
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Development
    • 8.4. Roche Diagnostics
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development
    • 8.5. Bayer AG
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Novartis AG
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Merck & Co., Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Seagen, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Pfizer, Inc.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Takeda Pharmaceutical Company Limited
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. GlaxoSmithKline plc
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product Portfolio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Targeted Therapeutics Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Targeted Therapeutics Marketattractiveness, By Type
6. Global Targeted Therapeutics Marketattractiveness, By Application
7. Global Targeted Therapeutics Marketattractiveness, By Distribution Channel
8. Global Targeted Therapeutics Marketshare by Type ,2020 and 2028 (USD Billion)
9. Global Targeted Therapeutics Marketby Monoclonal Antibodies, 2018–2028(USD Billion)
10. Global Targeted Therapeutics Marketby Small Molecular Inhibitors, 2018–2028(USD Billion)
11. Global Targeted Therapeutics Marketby Prodrug, 2018–2028(USD Billion)
12. Global Targeted Therapeutics Marketby Nano-Particulate Antibody Conjugates, 2018–2028(USD Billion)
13. Global Targeted Therapeutics Marketshare by Application ,2020 and 2028 (USD Billion)
14. Global Targeted Therapeutics Marketby Breast Cancer , 2018–2028(USD Billion)
15. Global Targeted Therapeutics Marketby Leukemia, 2018–2028(USD Billion)
16. Global Targeted Therapeutics Marketby Lung Cancer, 2018–2028(USD Billion)
17. Global Targeted Therapeutics Marketby Colorectal Cancer, 2018–2028(USD Billion)
18. Global Targeted Therapeutics Marketby Lymphoma,  2018–2028(USD Billion)
19. Global Targeted Therapeutics Marketby Renal Cancer, 2018–2028(USD Billion)
20. Global Targeted Therapeutics Marketby Multiple Sclerosis, 2018–2028(USD Billion)
21. Global Targeted Therapeutics Marketby Wet Age-Related Macular Degeneration, 2018–2028(USD Billion)
22. Global Targeted Therapeutics Marketshare by Distribution Channel ,2020 and 2028 (USD Billion)
23. Global Targeted Therapeutics Marketby Hospital Pharmacies , 2018–2028(USD Billion)
24. Global Targeted Therapeutics Marketby Online Pharmacies, 2018–2028(USD Billion)
25. Global Targeted Therapeutics Marketby Retail Pharmacies, 2018–2028(USD Billion)
26. Global Targeted Therapeutics Marketshare, by Region, 2020 and 2028
27. North America Targeted Therapeutics Market, 2018–2028(USD Billion)
28. Europe Targeted Therapeutics Market, 2018–2028(USD Billion)
29. Asia Pacific Targeted Therapeutics Market, 2018–2028(USD Billion)
30. Latin America Targeted Therapeutics Market, 2018–2028(USD Billion)
31. The Middle East and Africa Targeted Therapeutics Market, 2018–2028(USD Billion)
 


Table Of Tables

List of Tables

1. Global Targeted Therapeutics Market: snapshot
2. Drivers of the Targeted Therapeutics Market: impact analysis
3. North America Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
4. North America Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
5. North America Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
6. The U.S. Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
7. The U.S. Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
8. The U.S. Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
9. Rest of North America Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
10. Rest of North America Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
11. Rest of North America Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
12. Europe Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
13. Europe Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
14. Europe Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
15. UK Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
16. UK Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
17. UK Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
18. France Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
19. France Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
20. France Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
21. Germany Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
22. Germany Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
23. Germany Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
24. Rest of Europe Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
25. Rest of Europe Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
26. Rest of Europe Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
27. Asia Pacific Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
28. Asia Pacific Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
29. Asia Pacific Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
30. China Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
31. China Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
32. China Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
33. Japan Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
34. Japan Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
35. Japan Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
36. India Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
37. India Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
38. India Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
39. Rest of Asia Pacific Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
40. Rest of Asia Pacific Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
41. Rest of Asia Pacific Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
42. Latin America Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
43. Latin America Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
44. Latin America Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
45. Brazil Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
46. Brazil Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
47. Brazil Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
48. Rest of Latin America Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
49. Rest of Latin  America Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
50. Rest of Latin America Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
51. The Middle East and Africa Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
52. The Middle East and Africa Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
53. The Middle east and Africa Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
54. Saudi Arabia Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
55. Saudi Arabia Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
56. Saudi Arabia Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
57. South Africa Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
58. South Africa Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
59. South Africa Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)
60. Rest of the Middle East & Africa Targeted Therapeutics Market revenue, By Type  ,2018–2028(USD Billion)
61. Rest of the Middle East & Africa Targeted Therapeutics Market revenue, By Application  ,2018–2028(USD Billion)
62. Rest of the Middle East & Africa Targeted Therapeutics Market revenue, By Distribution Channel  ,2018–2028(USD Billion)

 

Methodology

FrequentlyAsked Questions

Targeted therapeutics are specialized medical treatments designed to precisely target and attack specific molecules or pathways involved in a disease, such as cancer. By focusing on diseased cells while sparing healthy ones, they enhance treatment effectiveness and reduce side effects compared to traditional therapies.

According to study, the Targeted Therapeutics Market size was worth around USD 108.54 billion in 2023 and is predicted to grow to around USD 202.93 billion by 2032.

The CAGR value of Targeted Therapeutics Market is expected to be around 7.2% during 2024-2032.

Asia Pacific has been leading the Targeted Therapeutics Market and is anticipated to continue on the dominant position in the years to come.

The Targeted Therapeutics Market is led by players like Amgen Inc., Sanofi, AstraZeneca, Roche Diagnostics, Bayer AG, Novartis AG, Merck & Co. Inc., Seagen Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, and GlaxoSmithKline plc.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed